The Baculovirus Expression System Expresses Chimeric RHDV VLPs as Bivalent Vaccine Candidates for Classic RHDV (GI.1) and RHDV2 (GI.2)

Background: Rabbit hemorrhagic disease (RHD) is an acute, hemorrhagic and highly lethal infectious disease caused by rabbit hemorrhagic disease virus (RHDV), which causes huge economic losses to the rabbit breeding industry. Moreover, there is limited cross-protection between the two different serot...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Yan Wang, Yiyang Fan, Ruixiang Bi, Yapeng Zhao, Wanning Gao, Derong Zhang, Jialin Bai
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Subjects:	rabbit hemorrhagic disease virus VP60 protein chimeric RHDV virus-like particle vaccine recombinant baculovirus expression system
Online Access:	https://www.mdpi.com/2076-393X/13/7/695

Similar Items

Immunogenicity of Multi-Target Chimeric RHDV Virus-Like Particles Delivering Foreign B-Cell Epitopes
by: María Zamora-Ceballos, et al.
Published: (2022-02-01)

Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs
by: Giselle Rangel, et al.
Published: (2021-05-01)

Simultaneous Occurrence of Field Epidemics of Rabbit Hemorrhagic Disease (RHD) in Poland Due to the Co-Presence of <i>Lagovirus europaeus</i> GI.1 (RHDV)/GI.1a (RHDVa) and GI.2 (RHDV2) Genotypes
by: Andrzej Fitzner, et al.
Published: (2025-09-01)

Facts about Wildlife Diseases: Rabbit Hemorrhagic Disease Virus Serotype 2 (RHDV2)
by: Catherine E. Dixon, et al.
Published: (2022-04-01)

Changes in MicroRNA Expression during Rabbit Hemorrhagic Disease Virus (RHDV) Infection
by: Beata Hukowska-Szematowicz, et al.
Published: (2020-08-01)

Overcoming species barriers: an outbreak of Lagovirus europaeus GI.2/RHDV2 in an isolated population of mountain hares (Lepus timidus)
by: Aleksija S. Neimanis, et al.
Published: (2018-11-01)

Surveillance of Wildlife Viruses: Insights from South Australia’s Monitoring of Rabbit Haemorrhagic Disease Virus (RHDV GI.1 and GI.2)
by: David E. Peacock, et al.
Published: (2024-09-01)

Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the Humoral Immune Protection Effect of VP60 Vaccine
by: Zhaoming Li, et al.
Published: (2023-08-01)

First detection and molecular characterization of rabbit hemorrhagic disease virus (RHDV) in Algeria
by: Lynda Sahraoui, et al.
Published: (2023-08-01)

Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits
by: Angela M. Bosco-Lauth, et al.
Published: (2024-03-01)

First Detection and Circulation of RHDV2 in New Zealand
by: Robyn N. Hall, et al.
Published: (2024-03-01)

Age and Infectious Dose Significantly Affect Disease Progression after RHDV2 Infection in Naïve Domestic Rabbits
by: Robyn N. Hall, et al.
Published: (2021-06-01)

Vimentin as a Cap of Invisibility: Proposed Role of Vimentin in Rabbit Hemorrhagic Disease Virus (RHDV) Infection
by: Małgorzata Blatkiewicz, et al.
Published: (2021-07-01)

Recombination between non-structural and structural genes as a mechanism of selection in lagoviruses: The evolutionary dead-end of an RHDV2 isolated from European hare
by: Patrizia Cavadini, et al.
Published: (2024-01-01)

Passive Immunisation against RHDV2 Induces Protection against Disease but Not Infection
by: Robyn N. Hall, et al.
Published: (2021-10-01)

Screening optimal DC-targeting peptide to enhance the immune efficacy of recombinant Lactobacillus expressing RHDV VP60
by: Tian Xia, et al.
Published: (2024-12-01)

Clinical Pathology Evaluation in Pet Rabbits Vaccinated Against Rabbit Hemorrhagic Disease Virus 2 (RHDV2)
by: Chris Griffin, et al.
Published: (2024-10-01)

Chimeric VLPs Bearing VP60 from Two Serotypes of <i>Rabbit Haemorrhagic Disease Virus</i> Are Protective against Both Viruses
by: Kevin P. Dalton, et al.
Published: (2021-09-01)

On the virome’s hidden diversity: lessons from RHDV
by: Ana M. Lopes, et al.
Published: (2023-12-01)

Characterization of the Maternally Derived Antibody Immunity against Rhdv-2 after Administration in Breeding Does of an Inactivated Vaccine
by: Massimiliano Baratelli, et al.
Published: (2020-08-01)

Epidemiological characterization and risk assessment of rabbit haemorrhagic disease virus 2 (RHDV2/b/GI.2) in the world
by: Zhuo Sun, et al.
Published: (2024-03-01)

Effect of propionobacterium and E.Coli lipopolysaccharide (inmunair 17.5) immunomodulator on response of rabbits to RHDV vaccine
by: M. A. Abdel-Khalek, et al.
Published: (2018-06-01)

Detections of Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Following the 2020 Outbreak in Wild Lagomorphs across the Western United States
by: Jourdan M. Ringenberg, et al.
Published: (2024-07-01)

A Review on the Methods Used for the Detection and Diagnosis of Rabbit Hemorrhagic Disease Virus (RHDV)
by: Joana Abrantes, et al.
Published: (2021-04-01)

Evaluation of comparative effect between aluminum hydroxide gel and montanide (ISA 70) in potency and protection of locally prepared rabbit hemorrhagic disease virus 2 (RHDV2) vaccines in rabbits
by: Doha Abd Alrahman Ahmed, et al.
Published: (2024-09-01)

Optimising the Delivery of RHDV to Rabbits for Biocontrol: An Experimental Evaluation of Two Novel Methods of Virus Delivery
by: Tshewang Dorji, et al.
Published: (2023-08-01)

Digital PCR (dPCR) Quantification of miR-155-5p as a Potential Candidate for a Tissue Biomarker of Inflammation in Rabbits Infected with <i>Lagovirus europaeus</i>/Rabbit Hemorrhagic Disease Virus (RHDV)
by: Beata Hukowska-Szematowicz, et al.
Published: (2023-07-01)

Epitope mapping of a neutralizing antibody against rabbit hemorrhagic disease virus GI.2
by: Ana Podadera, et al.
Published: (2025-04-01)

Modeling the response of an endangered rabbit population to RHDV2 and vaccination
by: Robin E. Russell, et al.
Published: (2024-02-01)

Baculovirus Display of Peptides and Proteins for Medical Applications
by: Aaron Pavel Rodríguez-Hernández, et al.
Published: (2023-02-01)

RNAi Inhibition of Rabbit Hemorrhagic Disease Virus (RHDV) Gene Expression in CHO Cell Line
by: Bilal Ghareeb
Published: (2008-04-01)

Viral haemorrhagic disease: RHDV type 2 ten years later
by: Lorenzo Capucci, et al.
Published: (2022-03-01)

Precocious Eimeria magna transgenically expressing RHDV P2 subdomain induces immune responses in rabbits
by: Wenxuan Chen, et al.
Published: (2025-07-01)

Establishment of a Novel Baculovirus–Silkworm Expression System
by: Junhong Wei, et al.
Published: (2022-05-01)

Stability and integrity of self-assembled bovine parvovirus virus‑like particles (BPV‑VLPs) of VP2 and combination of VP1VP2 assisted by baculovirus-insect cell expression: a potential logistical platform for vaccine deployment
by: Ashenafi Kiros Wubshet, et al.
Published: (2024-04-01)

Importance of Target Gene Locus on the Stability of Recombinant Viruses in the Baculovirus Expression System
by: Jong Ho Lee, et al.
Published: (2025-06-01)

Induction of Robust and Specific Humoral and Cellular Immune Responses by Bovine Viral Diarrhea Virus Virus-Like Particles (BVDV-VLPs) Engineered with Baculovirus Expression Vector System
by: Zhanhui Wang, et al.
Published: (2021-04-01)

MicroRNAs participate in the regulation of apoptosis and oxidative stress-related gene expression in rabbits infected with Lagovirus europaeus GI.1 and GI.2 genotypes
by: Ewa Ostrycharz, et al.
Published: (2024-03-01)

Iflavirus increases its infectivity and physical stability in association with baculovirus
by: Agata K. Jakubowska, et al.
Published: (2016-03-01)

Production of antiviral vaccine antigens using a silkworm-baculovirus expression system
by: Takahiro Kusakabe
Published: (2023-03-01)